Back to ACRS

BML Capital Management, LLC → ACRS

BML Capital Management, LLC ACRS Position History

Aclaris Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$57.6M
Q3 2026
Peak value
$63.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$27.1M
Q4 2025$42.9M
Q1 2026$53.4M
Q2 2026$63.3M
Q3 2026$57.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$57.6M10.96M——
Q2 2026$63.3M11.97M——
Q1 2026$53.4M14.25M——
Q4 2025$42.9M14.25M——
Q3 2025$27.1M14.25M——

Other funds holding ACRS

Other BML Capital Management, LLC positions

AVIR

ATEA PHARMACEUTICALS INC

$38M
AVIR

ATEA PHARMACEUTICALS INC

$35.2M
AVIR

ATEA PHARMACEUTICALS INC

$32.3M
AVIR

ATEA PHARMACEUTICALS INC

$26.7M
AVIR

ATEA PHARMACEUTICALS INC

$21.7M
ENGNW

ENGENE THERAPEUTICS INC

$13.3M
PPLC

PMV PHARMACEUTICALS INC

$12.2M
ENGNW

ENGENE THERAPEUTICS INC

$11.5M